Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines

被引：156

作者：

Barrett, P. Noel ^{[1
]}

Mundt, Wolfgang ^{[2
]}

Kistner, Otfried ^{[1
]}

Howard, M. Keith ^{[1
]}

机构：

[1] Baxter BioSci, Biomed Res Ctr, A-2304 Orth, Austria

[2] IZD Tower, Baxter BioSci, A-1220 Vienna, Austria

来源：

EXPERT REVIEW OF VACCINES | 2009年 / 8卷 / 05期

关键词：

continuous cell line; emerging virus disease; influenza; rotavirus; smallpox; Vero; viral vaccine; JAPANESE ENCEPHALITIS VACCINE; NILE-VIRUS ISOLATION; ATTENUATED VACCINE; INFLUENZA-VIRUS; PROTECTIVE EFFICACY; CLINICAL-TRIALS; EGG-ADAPTATION; CHIMERIVAX-JE; DENGUE; LIVE;

D O I：

10.1586/ERV.09.19

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The development of cell culture systems for virus propagation has led to major advances in virus vaccine development. Primary and diploid cell culture systems are now being replaced by the use of continuous cell lines (CCLs). These substrates are gaining increasing acceptance from regulatory authorities as improved screening technologies remove fears regarding their potential oncogenic properties. The Vero cell line is the most widely accepted CCL by regulatory authorities and has been used for over 30 years for the production of polio and rabies virus vaccines. The recent licensure of a Vero cell-derived live virus vaccine (ACAM2000, smallpox vaccine) has coincided with an explosion in the development of a range of new viral vaccines, ranging from live-attenuated pediatric vaccines against rotavirus infections to inactivated whole-virus vaccines against H5N1 pandemic influenza. These developments have illustrated the value of this cell culture platform in the rapid development of vaccines against a range of virus diseases.

引用

页码：607 / 618

页数：12

共 91 条

[31] Japanese encephalitis vaccine in travelers [J].

Jelinek, Tomas .

EXPERT REVIEW OF VACCINES, 2008, 7 (05) :689-693

[32] EFFICACY OF INACTIVATED INFLUENZA-A VIRUS (H3N2) VACCINES GROWN IN MAMMALIAN-CELLS OR EMBRYONATED EGGS [J].

KATZ, JM ;

WEBSTER, RG .

JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (02) :191-199

[33] Development of a mammalian cell (Vero) derived candidate influenza virus vaccine [J].

Kistner, O ;

Barrett, PN ;

Mundt, W ;

Reiter, M ;

Schober-Bendixen, S ;

Dorner, F .

VACCINE, 1998, 16 (9-10) :960-968

[34] Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses [J].

Kistner, Otfried ;

Howard, M. Keith ;

Spruth, Martin ;

Wodal, Walter ;

Bruehl, Peter ;

Gerencer, Marijan ;

Crowe, Brian A. ;

Savidis-Dacho, Helga ;

Livey, Ian ;

Reiter, Manfred ;

Mayerhofer, Ines ;

Tauer, Christa ;

Grillberger, Leopold ;

Mundt, Wolfgang ;

Falkner, Falko G. ;

Barrett, P. Noel .

VACCINE, 2007, 25 (32) :6028-6036

[35] The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans [J].

Kistner, Otfried ;

Barrett, Noel ;

Bruehmann, Axel ;

Reiter, Manfred ;

Mundt, Wolfgang ;

Savidis-Dacho, Helga ;

Schober-Bendixen, Susanne ;

Dorner, Friedrich ;

Aaskov, John .

VACCINE, 2007, 25 (25) :4845-4852

[36]

KITANO T, 1996, VACCINE HDB, P103

[37] Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine [J].

Kuzuhara, S ;

Nakamura, H ;

Hayashida, K ;

Obata, J ;

Abe, M ;

Sonoda, K ;

Nishiyama, K ;

Sugawara, K ;

Takeda, K ;

Honda, T ;

Matsui, H ;

Shigaki, T ;

Kino, Y ;

Mizokami, H ;

Tanaka, M ;

Mizuno, K ;

Ueda, K .

VACCINE, 2003, 21 (31) :4519-4526

[38]

Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4

[39] ABORTIVE INFECTION OF VERO CELLS BY AN INFLUENZA-A VIRUS (FPV) [J].

LAU, SC ;

SCHOLTISSEK, C .

VIROLOGY, 1995, 212 (01) :225-231

[40] TUMORIGENICITY OF VERO CELLS [J].

LEVENBOOK, IS ;

PETRICCIANI, JC ;

ELISBERG, BL .

JOURNAL OF BIOLOGICAL STANDARDIZATION, 1984, 12 (04) :391-&

← 1 2 3 4 5 6 7 8 9 10 →